Form 4: Cingulate Inc. EVP and COO Laurie Myers Granted Stock Options

Laurie Myers, EVP and COO of Cingulate Inc., was granted stock options for 98,944 shares of common stock on June 11, 2024.

Summary

• Laurie Myers, the EVP and COO of Cingulate Inc., received a stock option grant on June 11, 2024.
• The grant is for 98,944 shares of Cingulate Inc.'s common stock.
• The exercise price of the stock option is $1.18 per share.
• The stock option was approved by Cingulate Inc.'s board of directors on March 4, 2024, contingent on stockholder approval of an amendment to the company's equity incentive plan.
• Stockholder approval was obtained on June 11, 2024.
• The option vests with 50% vesting six months from the grant date, and the remaining shares vesting monthly over the following 30 months.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for executives.

Positives

• The grant of stock options to a key executive like the EVP and COO can be seen as an incentive to align their interests with the company's long-term success.

Industry Context

Stock options are a common form of executive compensation in the pharmaceutical industry, used to attract and retain talent and align their interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech and pharmaceutical industries.
• Companies like Amgen, Biogen, and Gilead Sciences routinely use stock options as part of their compensation strategy to incentivize performance and retain key personnel.
• The vesting schedule of 50% after six months and the remainder over 30 months is fairly typical, aligning with industry norms for incentivizing long-term commitment.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the EVP and COO to drive company performance.
• Employees may see this as a sign of confidence in the company's future.

Key Dates

Keywords

Stock Option, Cingulate Inc., Laurie Myers, EVP and COO, Equity Incentive Plan, Beneficial Ownership